A Case of Metastatic Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome-Associated Renal Cell Carcinoma Treated with a Sequence of Axitinib and Nivolumab Following Cytoreductive Nephrectomy

A Case of Metastatic Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome-Associated Renal Cell Carcinoma Treated with a Sequence of Axitinib and Nivolumab Following Cytoreductive Nephrectomy

Hereditary leiomyomatosis and renal cell cancer syndrome (HLRCC) associated renal cell carcinoma (RCC) is an aggressive form of type 2 papillary RCC caused by deficiency of the fumarate hydratase gene. For patients with metastatic disease, no standard treatment has been established with dismal progn...

Full description

Bibliographic Details
Main Authors: Ichiro Yonese, Masaya Ito, Kosuke Takemura, Takao Kamai, Fumitaka Koga
Format: Article
Language:English
Published: Codon Publications 2020-07-01
Series:Journal of Kidney Cancer and VHL
Subjects:
Metastatic Hereditary Leiomyomatosis
Renal Cell Cancer Syndrome
Renal Cell Carcinoma
Cytoreductive Nephrectomy
Axitinib
Nivolumab
Online Access:https://www.jkcvhl.com/index.php/jkcvhl/article/view/148

Internet

https://www.jkcvhl.com/index.php/jkcvhl/article/view/148

Similar Items